Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted to a single major therapeutic area. For each issue, an executive editor is chosen who is an acknowledged authority in that field.
 | |
| Discipline | Pharmacology and Medicinal Chemistry |
|---|---|
| Language | English |
| Edited by | Alessandro Antonelli |
| Publication details | |
| History | 1995-present |
| Publisher | |
| Frequency | 46/year |
| 2.208 (2019) | |
| Standard abbreviations | |
| ISO 4 | Curr. Pharm. Des. |
| Indexing | |
| CODEN | CPDEFP |
| ISSN | 1381-6128 (print) 1873-4286 (web) |
| OCLC no. | 33146703 |
| Links | |
The Journal is published by Bentham Science Publishers, which have faced criticism due to potentially predatory publishing tactics.
Abstracting and indexing
editCurrent Pharmaceutical Design is abstracted and indexed in:[1][2]
According to the Journal Citation Reports, the journal has a 2019 impact factor of 2.208.[3]
References
edit- ^ "List of indexing services". Current Pharmaceutical Design. Bentham Science Publishers. August 2011. Archived from the original on 2011-08-04. Retrieved 2011-08-04.
- ^ "Current Pharmaceutical Design". CAS Source Index (CASSI). American Chemical Society. August 2011. Retrieved 2011-08-04.
- ^ Journal home page
External links
edit
  | This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |